Hickson S, Ledger E, Wells T
NPJ Antimicrob Resist. 2025; 3(1):16.
PMID: 40016340
PMC: 11868545.
DOI: 10.1038/s44259-025-00087-2.
Kalia V, Patel S, Gong C, Lee J
Int J Mol Sci. 2025; 26(4).
PMID: 40004222
PMC: 11855700.
DOI: 10.3390/ijms26041755.
Eiferman V, Vion P, Bleibtreu A
Viruses. 2025; 17(1).
PMID: 39861912
PMC: 11768548.
DOI: 10.3390/v17010123.
Palma M, Qi B
Infect Dis Rep. 2024; 16(6):1127-1181.
PMID: 39728014
PMC: 11675988.
DOI: 10.3390/idr16060092.
Haq K, Figgitt M, Lee D
Can J Infect Dis Med Microbiol. 2024; 2024:6252415.
PMID: 39545100
PMC: 11563716.
DOI: 10.1155/2024/6252415.
The Potential of Phage Treatment to Inactivate Planktonic and Biofilm-Forming .
Martinho I, Braz M, Duarte J, Bras A, Oliveira V, Gomes N
Microorganisms. 2024; 12(9).
PMID: 39338470
PMC: 11433742.
DOI: 10.3390/microorganisms12091795.
Characterization and genomic analysis of PA-56 phage from Istanbul, Turkey: Antibacterial and antibiofilm efficacy alone and with antibiotics.
Damar Celik D, Karaynir A, Salih Dogan H, Bozdogan B, Ozbek Celik B
Heliyon. 2024; 10(17):e36243.
PMID: 39263065
PMC: 11387251.
DOI: 10.1016/j.heliyon.2024.e36243.
Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections.
Siopi M, Skliros D, Paranos P, Koumasi N, Flemetakis E, Pournaras S
Clin Microbiol Rev. 2024; 37(3):e0004424.
PMID: 39072666
PMC: 11391690.
DOI: 10.1128/cmr.00044-24.
Phage Therapy for Cardiac Implantable Electronic Devices and Vascular Grafts: A Targeted Literature Review.
Passerini M, Petri F, Suh G
Pathogens. 2024; 13(5).
PMID: 38787276
PMC: 11123972.
DOI: 10.3390/pathogens13050424.
Understanding the influence of the microbiome on childhood infections.
Heston S, Hurst J, Kelly M
Expert Rev Anti Infect Ther. 2024; 22(7):529-545.
PMID: 38605646
PMC: 11464204.
DOI: 10.1080/14787210.2024.2340664.
Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice.
Yang F, Labani-Motlagh A, Bohorquez J, Moreira J, Ansari D, Patel S
Commun Biol. 2024; 7(1):294.
PMID: 38461214
PMC: 10924958.
DOI: 10.1038/s42003-024-06006-x.
Improving phage therapy by evasion of phage resistance mechanisms.
Bleriot I, Pacios O, Blasco L, Fernandez-Garcia L, Lopez M, Ortiz-Cartagena C
JAC Antimicrob Resist. 2024; 6(1):dlae017.
PMID: 38343627
PMC: 10854218.
DOI: 10.1093/jacamr/dlae017.
Phage therapy as a glimmer of hope in the fight against the recurrence or emergence of surgical site bacterial infections.
Moghadam M, Mojtahedi A, Salamy S, Shahbazi R, Satarzadeh N, Delavar M
Infection. 2024; 52(2):385-402.
PMID: 38308075
DOI: 10.1007/s15010-024-02178-0.
Phage-host-immune system dynamics in bacteriophage therapy: basic principles and mathematical models.
Chae D
Transl Clin Pharmacol. 2024; 31(4):167-190.
PMID: 38196997
PMC: 10772058.
DOI: 10.12793/tcp.2023.31.e17.
The Safety and Efficacy of Phage Therapy for Infections in Cardiac and Peripheral Vascular Surgery: A Systematic Review.
Simpson E, MacLeod C, Stacey H, Nagy J, Jones J
Antibiotics (Basel). 2023; 12(12).
PMID: 38136718
PMC: 10740750.
DOI: 10.3390/antibiotics12121684.
Bacteriophage treatment as an alternative therapy for multidrug-resistant bacteria.
Alqahtani A
Saudi Med J. 2023; 44(12):1222-1231.
PMID: 38016738
PMC: 10712800.
DOI: 10.15537/smj.2023.44.12.20230366.
Phage therapy: a revolutionary shift in the management of bacterial infections, pioneering new horizons in clinical practice, and reimagining the arsenal against microbial pathogens.
Karn S, Gangwar M, Kumar R, Bhartiya S, Nath G
Front Med (Lausanne). 2023; 10:1209782.
PMID: 37928478
PMC: 10620811.
DOI: 10.3389/fmed.2023.1209782.
The Safety of Bacteriophages in Treatment of Diseases Caused by Multidrug-Resistant Bacteria.
Chung K, Nang S, Tang S
Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895818
PMC: 10610463.
DOI: 10.3390/ph16101347.
Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections.
Ouyang X, Li X, Song J, Wang H, Wang S, Fang R
Front Microbiol. 2023; 14:1277178.
PMID: 37840750
PMC: 10568470.
DOI: 10.3389/fmicb.2023.1277178.
Insights on Current Strategies to Decolonize the Gut from Multidrug-Resistant Bacteria: Pros and Cons.
Roson-Calero N, Balleste-Delpierre C, Fernandez J, Vila J
Antibiotics (Basel). 2023; 12(6).
PMID: 37370393
PMC: 10295446.
DOI: 10.3390/antibiotics12061074.